Experiment Overview
| Repository ID: | FR-FCM-Z7JL | Experiment name: | MiR-301b-3p promotes breast cancer progression through inhibiting the expression of TGFBR2 | MIFlowCyt score: | 18.00% |
| Primary researcher: | Xiaozhen Ying | PI/manager: | Xiaozhen Ying | Uploaded by: | Xiaozhen Ying |
| Experiment dates: | 2023-01-18 - | Dataset uploaded: | May 2024 | Last updated: | May 2024 |
| Keywords: | None | Manuscripts: | |||
| Organizations: | None | ||||
| Purpose: | Breast cancer (BC) as a popular malignancy posed serious threating to women?s life and health. This study explored how miR-301b-3p and transforming growth factor-beta receptor 2 (TGFBR2) affected BC progression. | ||||
| Conclusion: | The present findings demonstrated that an essential role of miR-301b-3p in promoting tumor growth, invasion and migration and anti-apoptosis, and targeted the TGFBR2 to inhibit its tumor suppressor function. | ||||
| Comments: | None | ||||
| Funding: | Not disclosed | ||||
| Quality control: | None | ||||
